Home ›
Entities
› academia
› Two‐stage designs versus <scp>E</scp>uropean scaled average designs in bioequivalence studies for highly variable drugs: Which to choose?
Two‐stage designs versus <scp>E</scp>uropean scaled average designs in bioequivalence studies for highly variable drugs: Which to choose?
Research article (Statistics in Medicine, 2017) · cited 11× · AI/ML
Two‐stage designs versus European scaled average designs in bioequivalence studies for highly variable drugs: Which to choose?
Summary
Two‐stage designs versus European scaled average designs in bioequivalence studies for highly variable drugs: Which to choose? is a scholarly article[1].
Key Facts
Two‐stage designs versus European scaled average designs in bioequivalence studies for highly variable drugs: Which to choose?'s instance of is recorded as scholarly article[2].
References
Programmatic citations — every numbered marker resolves to a verifiable graph row below.
Use these citations when quoting this entity in research, articles, AI prompts, or wherever provenance matters. We aggregate Wikidata + Wikipedia + authoritative open-data sources; the stitched, scored, cross-referenced view is what 4ort.xyz contributes.
APA4ort.xyz Knowledge Graph. (2026). Two‐stage designs versus <scp>E</scp>uropean scaled average designs in bioequivalence studies for highly variable drugs: Which to choose?. Retrieved May 24, 2026, from https://4ort.xyz/entity/twostage-designs-versus-scp-e-scp-uropean-scaled-average-designs-in-bioequivalence-studies-for-highly-variable-drugs-whi
MLA“Two‐stage designs versus <scp>E</scp>uropean scaled average designs in bioequivalence studies for highly variable drugs: Which to choose?.” 4ort.xyz Knowledge Graph, 4ort.xyz, 24 May. 2026, https://4ort.xyz/entity/twostage-designs-versus-scp-e-scp-uropean-scaled-average-designs-in-bioequivalence-studies-for-highly-variable-drugs-whi.
BibTeX@misc{4ortxyz_twostage-designs-versus-scp-e-scp-uropean-scaled-average-designs-in-bioequivalence-studies-for-highly-variable-drugs-whi_2026, author = {{4ort.xyz Knowledge Graph}}, title = {{Two‐stage designs versus <scp>E</scp>uropean scaled average designs in bioequivalence studies for highly variable drugs: Which to choose?}}, year = {2026}, url = {https://4ort.xyz/entity/twostage-designs-versus-scp-e-scp-uropean-scaled-average-designs-in-bioequivalence-studies-for-highly-variable-drugs-whi}, note = {Accessed: 2026-05-24}}
LLM promptAccording to 4ort.xyz Knowledge Graph (aggregator of Wikidata, Wikipedia, and authoritative open-data sources): Two‐stage designs versus <scp>E</scp>uropean scaled average designs in bioequivalence studies for highly variable drugs: Which to choose? — https://4ort.xyz/entity/twostage-designs-versus-scp-e-scp-uropean-scaled-average-designs-in-bioequivalence-studies-for-highly-variable-drugs-whi (retrieved 2026-05-24)
